Study Preview
Study Title and Description
Suburethral sling materials: Best outcome with autologous tissue
Key Questions Addressed
2 | Sling Adverse Events |
Primary Publication Information
Title | Suburethral sling materials: Best outcome with autologous tissue |
Author | Simsiman AJ, Powell CR, Stratford RR, Menefee SA. |
Country | -- |
Year | 2005 |
Numbers |
Pubmed ID: 16325625 15 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Fascial PVS | Rectus or fascia lata | |
2 | Cadaveric PVS | Use of cadaveric fascia for pubovaginal sling (allograft) | |
3 | Xenograft PVS |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | Retrospective nonrandom (2+ slings analyzed separately) | ||
Study Country | US | ||
Sling Category | Pubovaginal (bladder neck) | ||
Multicenter? | No | ||
Institution Type | Community hospital | ||
No. of Surgeons Performing the Procedures ... | Other ... | 3 Attending surgeons | |
Surgeons' Training | Urogynecology | ||
Urology | |||
Residents or Fellows Performing the Surgery? | Yes | ||
Adverse Event Ascertainment | Passive | ||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported | ||
Study Sponsor/Funding | Not reported | ||
Comments (overall study) | Retrospective and very little information provided about AEs or which AEs were looked for. |
Results & Comparisons
No Results found.
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
Fascial PVS | Obstruction requiring reoperation | Prolonged postoperative voiding dysfunction or persistent irritative symptoms | 23 ± 14 mo (mean ± SD) | after discharge | yes | no | 4 | 78 | ND | ND | |
Cadaveric PVS | 25 ± 14 mo | after discharge | 4 | 80 | |||||||
Xenograft PVS | 17 ± 6 mo | after discharge | 2 | 83 | |||||||
Total | |||||||||||
Fascial PVS | Organ injury in OR (urethra, bladder, bowel) | Ureteral injury required reimplantation; likely related to concomitant uterosacral colpopexy | 23 ± 14 mo (mean ± SD) | unclear | yes | no | 1 | 78 | ND | ND | |
Cadaveric PVS | 25 ± 14 mo | 0 | 80 | ||||||||
Xenograft PVS | 17 ± 6 mo | 0 | 83 | ||||||||
Total | |||||||||||
Fascial PVS | Organ injury in OR (urethra, bladder, bowel) | Cystotomies | 23 ± 14 mo (mean ± SD) | unclear | 3 | 78 | |||||
Cadaveric PVS | 25 ± 14 mo | 1 | 80 | ||||||||
Xenograft PVS | 17 ± 6 mo | 0 | 83 | ||||||||
Total | |||||||||||
Fascial PVS | DVT | DVT immediate postoperative period | 1 | 78 | |||||||
Cadaveric PVS | unclear | 0 | 80 | ||||||||
Xenograft PVS | 0 | 83 | |||||||||
Total |